CLU and cancer: Remarkably, when the researchers reduced CLU expressions, it disrupted the mitochondrial metabolism of the cells, leading to the accumulation of deleterious mitochondrial superoxide, thereby augmenting the sensitivity of the cancer cells to cisplatin treatment [56].